risperidone has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone was well tolerated in the elderly and associated with a low risk of movement disorders and anticholinergic effects." | 2.42 | Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. ( DeVane, CL; Mintzer, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeVane, CL | 1 |
| Mintzer, J | 1 |
1 review available for risperidone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
Topics: Aged; Antipsychotic Agents; Humans; Mental Disorders; Neurodegenerative Diseases; Risperidone | 2003 |